moxisylyte has been researched along with Catatonic Rigidity in 1 studies
Moxisylyte: An alpha-adrenergic blocking agent that is used in Raynaud's disease. It is also used locally in the eye to reverse the mydriasis caused by phenylephrine and other sympathomimetic agents. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1312)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| White, C | 1 |
| Richens, A | 1 |
1 trial available for moxisylyte and Catatonic Rigidity
| Article | Year |
|---|---|
Letter: Thymoxamine and spasticity.
Topics: Administration, Oral; Clinical Trials as Topic; Diazepam; Humans; Injections, Intravenous; Moxisylyt | 1974 |